abrdn Healthcare Funds File Definitive Proxy Statement
Ticker: THQ · Form: DEF 14A · Filed: Apr 22, 2024 · CIK: 1604522
| Field | Detail |
|---|---|
| Company | Abrdn Healthcare Opportunities Fund (THQ) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy statement, healthcare fund, abrdn, SEC filing, shareholder meeting
TL;DR
<b>abrdn Healthcare Funds File Definitive Proxy Statement on April 22, 2024.</b>
AI Summary
abrdn Healthcare Opportunities Fund (THQ) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. abrdn Healthcare Investors filed a Definitive Proxy Statement on April 22, 2024. The filing pertains to the abrdn World Healthcare Fund (Central Index Key: 0001635977). It also covers abrdn Healthcare Opportunities Fund (Central Index Key: 0001604522). The fiscal year end for these funds is September 30. The filing address is 1900 Market Street, Suite 200, Philadelphia, PA 19103.
Why It Matters
For investors and stakeholders tracking abrdn Healthcare Opportunities Fund, this filing contains several important signals. This filing is a standard regulatory requirement for publicly traded funds to inform shareholders about upcoming meetings and proposals. Shareholders of abrdn World Healthcare Fund and abrdn Healthcare Opportunities Fund should review this document for important information regarding their investments.
Risk Assessment
Risk Level: low — abrdn Healthcare Opportunities Fund shows low risk based on this filing. The filing is a routine proxy statement with no immediate financial or operational impact indicated.
Analyst Insight
Shareholders should review the proxy statement for details on voting matters and fund governance.
Key Numbers
- 2024-04-22 — Filing Date (Date the Definitive Proxy Statement was filed)
- 0930 — Fiscal Year End (Fiscal year end for the funds)
Key Players & Entities
- abrdn Healthcare Investors (company) — Registrant
- abrdn World Healthcare Fund (company) — Registrant
- abrdn Healthcare Opportunities Fund (company) — Registrant
- 0001635977 (company) — Central Index Key for abrdn World Healthcare Fund
- 0001604522 (company) — Central Index Key for abrdn Healthcare Opportunities Fund
- 1900 Market Street, Suite 200, Philadelphia, PA 19103 (company) — Business Address
FAQ
When did abrdn Healthcare Opportunities Fund file this DEF 14A?
abrdn Healthcare Opportunities Fund filed this Proxy Statement (DEF 14A) with the SEC on April 22, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by abrdn Healthcare Opportunities Fund (THQ).
Where can I read the original DEF 14A filing from abrdn Healthcare Opportunities Fund?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by abrdn Healthcare Opportunities Fund.
What are the key takeaways from abrdn Healthcare Opportunities Fund's DEF 14A?
abrdn Healthcare Opportunities Fund filed this DEF 14A on April 22, 2024. Key takeaways: abrdn Healthcare Investors filed a Definitive Proxy Statement on April 22, 2024.. The filing pertains to the abrdn World Healthcare Fund (Central Index Key: 0001635977).. It also covers abrdn Healthcare Opportunities Fund (Central Index Key: 0001604522)..
Is abrdn Healthcare Opportunities Fund a risky investment based on this filing?
Based on this DEF 14A, abrdn Healthcare Opportunities Fund presents a relatively low-risk profile. The filing is a routine proxy statement with no immediate financial or operational impact indicated.
What should investors do after reading abrdn Healthcare Opportunities Fund's DEF 14A?
Shareholders should review the proxy statement for details on voting matters and fund governance. The overall sentiment from this filing is neutral.
How does abrdn Healthcare Opportunities Fund compare to its industry peers?
The filing relates to investment funds focused on the healthcare sector.
Are there regulatory concerns for abrdn Healthcare Opportunities Fund?
The filing is made under the Securities Exchange Act of 1934, specifically Schedule 14A, which governs proxy solicitations.
Industry Context
The filing relates to investment funds focused on the healthcare sector.
Regulatory Implications
The filing is made under the Securities Exchange Act of 1934, specifically Schedule 14A, which governs proxy solicitations.
What Investors Should Do
- Review the proxy statement for details on voting procedures and proposals.
- Check for any changes in fund management or investment strategy.
- Consult with a financial advisor regarding any investment decisions based on the proxy statement.
Year-Over-Year Comparison
This is a routine filing and does not appear to be a comparison to a previous filing.
Filing Stats: 4,535 words · 18 min read · ~15 pages · Grade level 11.9 · Accepted 2024-04-22 16:13:55
Filing Documents
- tm2410797d16_def14a.htm (DEF 14A) — 238KB
- j241079717_ba001.jpg (GRAPHIC) — 19KB
- j241079717_ba002.jpg (GRAPHIC) — 5KB
- j241079717_ba003.jpg (GRAPHIC) — 5KB
- tm2410797d16_hqhprximg01.jpg (GRAPHIC) — 136KB
- tm2410797d16_hqhprximg02.jpg (GRAPHIC) — 131KB
- tm2410797d16_thqprximg01.jpg (GRAPHIC) — 137KB
- tm2410797d16_thqprximg02.jpg (GRAPHIC) — 131KB
- tm2410797d16_thwproximg01.jpg (GRAPHIC) — 136KB
- tm2410797d16_thwproximg02.jpg (GRAPHIC) — 136KB
- 0001104659-24-049994.txt ( ) — 1395KB
From the Filing
DEF 14A 1 tm2410797d16_def14a.htm DEF 14A        UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A   SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )   Filed by the Registrant      ☒ Filed by a Party other than the Registrant       ☐ Check the appropriate box:   ☐         Preliminary Proxy Statement ☐         Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒         Definitive Proxy Statement ☐         Definitive Additional Materials ☐         Soliciting Material under §240.14a-12     abrdn Healthcare Investors abrdn Healthcare Opportunities Fund abrdn World Healthcare Fund (Name of Registrant as Specified In Its Charter)     (Name of Person(s) Filing Proxy Statement, if other than the Registrant)   Payment of Filing Fee (Check the appropriate box):   ☒        No fee required.   ☐         Fee paid previously with preliminary materials.   ☐         Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(l) and 0-11.         ABRDN HEALTHCARE INVESTORS ABRDN HEALTHCARE OPPORTUNITIES FUND ABRDN WORLD HEALTHCARE FUND 1900 Market Street, Suite 200 Philadelphia, PA 19103 NOTICE OF ANNUAL MEETINGS OF SHAREHOLDERS To be held on June 25, 2024 TO THE SHAREHOLDERS: NOTICE IS HEREBY GIVEN that the annual meeting of shareholders of each of abrdn Healthcare Investors (formerly, Tekla Healthcare Investors), abrdn Healthcare Opportunities Fund (formerly, Tekla Healthcare Opportunities Fund) and abrdn World Healthcare Fund (formerly, Tekla World Healthcare Fund) (each, a "Fund," and collectively, the "Funds") and any adjournments or postponements thereof will be held at the offices of abrdn Inc., located at 1900 Market Street, Suite 200, Philadelphia, PA 19103 (each meeting, an "Annual Meeting," and collectively, the "Annual Meetings") on the following dates and at the following times: abrdn Healthcare Investors (NYSE: HQH)   June 25, 2024   12:30 p.m. Eastern Time   abrdn Healthcare Opportunities Fund (NYSE: THQ)   June 25, 2024   1:00 p.m. Eastern Time   abrdn World Healthcare Fund (NYSE: THW)   June 25, 2024   1:30 p.m. Eastern Time   The purpose of the Annual Meetings is to consider and act upon the following proposals (each, a "Proposal") for each Fund, as applicable, and to consider and act upon such other matters as may properly come before the Annual Meetings or any adjournments or postponements thereof: HQH — To elect two Class B Trustees to serve until the 2027 Annual Meeting of Shareholders or until such Trustee's successor is duly elected and qualified. THQ — To elect two Class A Trustees to serve until the 2027 Annual Meeting of Shareholders or until such Trustee's successor is duly elected and qualified. THW — To elect two Class C Trustees to serve until the 2027 Annual Meeting of Shareholders or until such Trustee's successor is duly elected and qualified. Each Proposal is discussed in greater detail in the enclosed Joint Proxy Statement. You are entitled to notice of, and to vote at, the Annual Meeting of a Fund if you owned shares of such Fund at the close of business on April 1, 2024 (the "Record Date"). Even if you expect to attend an Annual Meeting, please complete, date, sign and return the enclosed proxy card(s) in the enclosed postage-paid envelope or authorize your proxy by telephone or through the Internet. We will admit to an Annual Meeting (1) all shareholders of record on the Record Date, (2) persons holding proof of beneficial ownership on the Record Date, such as a letter or account statement from the person's broker, (3) persons who have been granted proxies, and (4) such other persons that we, in our sole discretion, may elect to admit. All persons wishing to be admitted to an Annual Meeting must present photo identification. If you plan to attend an Annual Meeting, we ask that you call us in advance at 1-800-522-5465. This Notice and related proxy materials are first being mailed to shareholders on or about April 22, 2024. Important Notice Regarding the Availability of Proxy